Evidence map›Paper›PMID 42004287›Full record

ReviewVeterinary evidence

The therapeutic effectiveness of oral cannabidiol in addition to current treatment in cats with osteoarthritis.

Oliver Wilkinson

Abstract readReview
In one paragraph

Review in Veterinary evidence. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Oliver WilkinsonUniversity of Bristol, United Kingdom.ORCID https://orcid.org/0009-0006-1992-4694

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PICO question: In cats with osteoarthritis (OA), does the oral supplementation of cannabidiol (CBD) oil, compared to conventional treatment alone, improve treatment outcomes of reducing pain and improving locomotion? Clinical bottom line: Category of research: Treatment. Number and type of study designs reviewed: No papers were found relevant to the PICO. Strength of evidence: Zero. Outcomes reported: No studies relevant to the PICO were found (in English) on the use of CBD in cats with OA. Conclusion: There is currently no evidence to recommend the use of CBD in cats for the treatment of OA and further studies on therapeutic use of CBD in cats with OA are required.

Indexed as

cannabidoilcannabinoidcatcbdfelinelocomotionoaosteoarthritispain

Identifiers

PMID42004287
PMCPMC12710401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.